BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3938732)

  • 1. Modulation of postinhibitory increase in plasma prolactin by domperidone in patients with prolactin secreting adenoma.
    Hanew K; Sato S; Sasaki A; Goh M; Shimizu Y; Murakami O; Yoshinaga K
    Endocrinol Jpn; 1985 Dec; 32(6):811-7. PubMed ID: 3938732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of trh and dopaminergic mechanisms in the regulation of stimulated prolactin release in man.
    Ho KY; Smythe GA; Lazarus L
    Clin Endocrinol (Oxf); 1985 Jul; 23(1):7-16. PubMed ID: 3928213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin and TSH responses to both domperidone and TRH in normal and hyperprolactinaemic women after dopamine synthesis blockade.
    Ghigo E; Goffi S; Molinatti GM; Camanni F; Massara F
    Clin Endocrinol (Oxf); 1985 Aug; 23(2):155-60. PubMed ID: 3931942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catecholamines and pituitary function. III. Restoration of the prolactin response to thyrotropin-releasing hormone by low-dose dopamine infusion in women with pathological hyperprolactinemia.
    Nicoletti I; Filipponi P; Fedeli L; Sfrappini M; Gregorini G; Ambrosi F; Santeusanio F
    Horm Res; 1984; 20(3):202-12. PubMed ID: 6436160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic mechanisms regulating prolactin secretion in patients with prolactin-secreting pituitary adenoma. Long-term studies after selective transsphenoidal surgery.
    Barbarino A; De Marinis L; Anile C; Menini E; Merlini G; Maira G
    Metabolism; 1982 Nov; 31(11):1100-4. PubMed ID: 6813636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inability of dynamic tests of prolactin and TSH secretion to differentiate between tumorous and non-tumorous hyperprolactinemia.
    Prescott RW; Johnston DG; Taylor PK; Haigh J; Weightman DR; Hall K; Cook DB
    J Endocrinol Invest; 1985 Feb; 8(1):49-54. PubMed ID: 3921596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of transient dopamine antagonism on thyrotropin-releasing hormone-induced prolactin release in pseudopregnant rats.
    Haisenleder DJ; Moy JA; Gala RR; Lawson DM
    Endocrinology; 1986 Nov; 119(5):1989-95. PubMed ID: 3095097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TSH and prolactin responses to thyrotropin releasing hormone (TRH) and domperidone in patients with empty sella syndrome.
    Valensi P; Combes ME; Perret G; Attali JR
    J Endocrinol Invest; 1996 May; 19(5):293-7. PubMed ID: 8796337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The preoperative and postoperative investigation of TSH and prolactin release in the management of patients with hyperprolactinaemia due to prolactinomas and nonfunctional pituitary tumours: relationship to adenoma size at surgery.
    Scanlon MF; Peters JR; Salvador J; Richards SH; John R; Howell S; Williams ED; Thomas JP; Hall R
    Clin Endocrinol (Oxf); 1986 Apr; 24(4):435-46. PubMed ID: 3091297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysfunction of dopaminergic regulation of prolactin in patients with functioning and nonfunctioning pituitary adenomas and craniopharyngiomas.
    Martinez-Campos A; Cornejo J; Garza-Flores J; Velasco F
    Fertil Steril; 1985 Oct; 44(4):471-7. PubMed ID: 4054318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function.
    Scanlon MF; Rodriguez-Arnao MD; McGregor AM; Weightman D; Lewis M; Cook DB; Gomez-Pan A; Hall R
    Clin Endocrinol (Oxf); 1981 Feb; 14(2):133-43. PubMed ID: 6790201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin and thyrotropin response to blockade of dopamine synthesis by monoiodotyrosine in subjects with postpartum and pathological hyperprolactinemia.
    Ghigo E; Ciccarelli E; Novelli A; Massobrio M; Müller EE; Camanni F
    J Endocrinol Invest; 1985 Feb; 8(1):35-40. PubMed ID: 3989236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TSH and PRL responses to domperidone and TRH in men with insulin-dependent diabetes mellitus of different duration.
    Coiro V; Butturini U; Gnudi A; Volpi R; d'Amato L; Speroni G; Capretti L; Roti E; Chiodera P
    Horm Res; 1987; 25(4):206-14. PubMed ID: 3108134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of transient dopamine antagonism on thyrotropin-releasing hormone-induced prolactin release in pregnant rats.
    Haisenleder DJ; Moy JA; Gala RR; Lawson DM
    Endocrinology; 1986 Nov; 119(5):1980-8. PubMed ID: 3095096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the central and peripheral dopaminergic control of PRL secretion in man: failure to demonstrate the existence of a dopamine-mediated prolactin-inhibiting factor.
    Ho KY; Smythe GA; Lazarus L
    Neuroendocrinology; 1985 Jun; 40(6):457-62. PubMed ID: 3925361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of repeated stimuli on prolactin release in vitro from normal and adenomatous rat lactotrophs.
    Lafond J; Collu R
    Mol Cell Endocrinol; 1986 Sep; 47(1-2):175-81. PubMed ID: 3091427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of dopaminergic tone in hyperprolactinemia. III. Thyroid-stimulating hormone response to metoclopramide in differential diagnosis and postoperative follow-up of prolactinoma patients.
    De Marinis L; Mancini A; Minnielli S; Masala R; Anile C; Maira G; Barbarino A
    Metabolism; 1985 Oct; 34(10):917-22. PubMed ID: 4046835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of postinhibitory rebound increases in plasma gh in acromegalic patients.
    Hanew K; Sasaki A; Sato S; Kasai M; Shimizu Y; Murakami O; Yoshinaga K
    Tohoku J Exp Med; 1984 Jan; 142(1):59-65. PubMed ID: 6144195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for lactotroph dopamine resistance in idiopathic hyperprolactinemia.
    Webb CB; Thominet JL; Barowsky H; Berelowitz M; Frohman LA
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1089-93. PubMed ID: 6841551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect.
    Rodriguez-Arnao MD; Peters JR; Foord SM; Dieguez C; Edwards C; Gomez-Pan A; Hall R; Newcombe RG; Scanlon MF
    J Clin Endocrinol Metab; 1983 Nov; 57(5):975-80. PubMed ID: 6619271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.